NCT01365455 · Interventional trial
Efficacy and Safety of Subcutaneous Secukinumab for Moderate to Severe Chronic Plaque-type Psoriasis for up to 1 Year
Overall registry status Completed
Phase 3
Conditions Moderate to Severe Plaque-type Psoriasis
Delaware Valley sites
- Novartis Investigative Site · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory